All episodes
My LDL Was 192. Then I Found the First PCSK9 Pill.
Published August 14, 202623:03The Longevity Show
My LDL was 192 even though I felt healthy. That result sent me into the story of PCSK9—a protein discovered outside cholesterol research that became the t…
My LDL was 192 even though I felt healthy. That result sent me into the story of PCSK9—a protein discovered outside cholesterol research that became the target of injections, RNA silencing, the first oral PCSK9 inhibitor, and now one-time gene-editing experiments.
This episode follows the human genetics, LDL-receptor biology, and three engineering problems behind Lipfendra/enlicitide. The pill has proven potent LDL and ApoB lowering; its dedicated cardiovascular-outcomes trial is still ongoing.
Chapters
Get The Longevity Letter
Weekly longevity science and what I would actually do with it.
